Abstract
Given the unsatisfactory survival in patients who received high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) for peripheral T-cell lymphomas (PTCLs), we conducted a prospective trial of busulfan (Bu), etoposide (E), cytarabine (A), and melphalan (M) (BuEAM), including IV Bu instead of carmustine (BCNU) as in standard BEAM, as a high-dose regimen in such patients. This study evaluated the efficacy and toxicity of BuEAM as a high-dose regimen for ASCT in patients with T-cell lymphomas. The high-dose chemotherapy at seven centers in Korea included Bu (3.2 mg/kg IV qd from day 6 to day 5), E (200 mg/m2 IV bid on day 4 and day 3), A (1 g/m2 IV qd on day 4 and day 3), and M (140 mg/m2 IV qd on day 2). Eighty-one patients were enrolled in this study. The main subtypes were peripheral T-cell lymphoma, not other specified (n = 32, 39.5%), NK/T-cell lymphoma (n = 22, 27.5%), and angioimmunoblastic T-cell lymphoma (n = 12, 14.8%). Upfront and salvage ASCTs were performed in 65 (80.2%) and 16 (19.8%) patients, respectively. The disease status of the patients before ASCT was 54 patients (66.7%) with complete response and 27 patients (33.3%) with partial response. The common grade-III toxicities were anorexia (8....Continue Reading
References
Dec 7, 1995·The New England Journal of Medicine·T PhilipJ L Harousseau
Feb 16, 2000·Bone Marrow Transplantation·E P AlessandrinoC Bernasconi
Dec 7, 2000·Bone Marrow Transplantation·M S AkashehD H Vesole
Mar 27, 2004·The New England Journal of Medicine·Noel MilpiedUNKNOWN Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang
Sep 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RodriguezE Conde
Jul 28, 2006·Leukemia·P CorradiniS Cortelazzo
Jan 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RodríguezM D Caballero
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Jun 26, 2007·Bone Marrow Transplantation·S FeylerG Cook
Aug 22, 2007·Annals of Hematology·Jae-Cheol JoCheolwon Suh
Feb 28, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MercadalUNKNOWN Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
Mar 25, 2008·Therapeutics and Clinical Risk Management·D'Hondt LionelCanon Jean-Luc
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Nov 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter ReimerMartin Wilhelm
Jul 15, 2009·Bone Marrow Transplantation·A NumataUNKNOWN Fukuoka Blood and Marrow Transplantation Group
Aug 6, 2010·Leukemia Research·Jeong Eun KimCheolwon Suh
Jul 12, 2012·The Korean Journal of Hematology·Jae-Cheol JoCheolwon Suh
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco d'AmoreHelle E Toldbod
Jan 30, 2013·Annals of Hematology·Jae-Sook AhnJe-Jung Lee
Mar 26, 2016·American Journal of Hematology·Clinton YamSunita D Nasta
Jun 1, 2016·Leukemia & Lymphoma·Alessandro IsidoriGiuseppe Visani
May 10, 2017·Current Hematologic Malignancy Reports·Umar ZahidFaiz Anwer
Dec 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FossardE Bachy
Aug 15, 2019·Journal of Cancer Research and Clinical Oncology·Malte RoerdenWichard Vogel
Apr 19, 2020·Bone Marrow Transplantation·Jae-Cheol JoWon-Sik Lee